Can we better evaluate responses in higher-risk myelodysplastic syndromes?

Lin-Pierre Zhao1, Pierre Fenaux2

  • 1Université Paris Cité, INSERM UMR 1342, Institut de Recherche Saint-Louis, Paris, France; Leukemia Institute Paris Saint-Louis, Paris, France; Service Hématologie Seniors, Assistance Publique des Hôpitaux de Paris (APHP), Université Paris Cité, Paris.

Haematologica
|October 29, 2026
PubMed

Related Concept Videos